Bionsight @ BIO International Convention 2026
Bionsight at the BIO International Convention 2026
Bionsight participated in the BIO International Convention 2026, held from June 22–25 in San Diego, USA — the largest and most comprehensive event for the global biotechnology industry.
Bionsight’s Chief Scientific Officer, Namgil Lee, attended the convention to promote the company and to advance business development through partnering meetings with global pharmaceutical companies. At the Korea Pavilion Open Stage (booth #3735), he delivered a company pitch introducing Bionsight’s probe-free chemoproteomics for first-in-class antibody and ADC target discovery — under the message “AI predicts anything. We validate them.”
Through this participation, Bionsight strengthened its global network and explored new opportunities for collaboration and partnership with leading players across the biopharmaceutical ecosystem.
The BIO International Convention brings together more than 20,000 industry leaders from across the globe, representing the full biotech ecosystem — from pharmaceutical companies and biotech startups to academia, investors, and government agencies.